Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · DEEPAKFERT

DEEPAK FERT.

CommoditiesChemicals & Petrochemicals₹18701 cr market cap
₹1449.90 ▼ -2.07% today As of 19 Nov 2026
52-week low ₹872.1052-week high ₹1664.30

-11.0% from the 52-week high · +69.8% above the low

Deepak Fertilisers & Petrochemicals Corp. Ltd. engages in the manufacture of industrial chemicals and fertilizers. The company is headquartered in Pune, Maharashtra and currently employs 941 full-time employees. The company also has operations in value added real estate. The firm operates through three segments: Chemicals, Bulk Fertilizers, and Realty. Its Chemicals segment offers products, such as ammonia, methanol, dilute nitric acid, concentrated nitric acid, carbon dioxide (CO2), technical ammonium nitrate, iso-propyl alcohol, propane, bulk, and specialty chemicals. Its Bulk Fertilizers segment offers products, such as nitro phosphate (NP), muriate of potash, diammonium phosphate (DAP), single super phosphate, Sulphur, micronutrients, single superphosphate (SSF) and bio fertilizers. Its Realty segment includes the real estate business. Its Windmill segment includes windmill power. The company offers a range of NP, nitrogen phosphorous potassium variants, water soluble fertilizers and bentonite Sulphur to Indian farmers under its Mahadhan brand.

The short version. DEEPAK FERT. reported revenue of ₹3,256 crore for Jun 2026, up 22.5% from a year earlier. Net profit was ₹490 crore (up 101.6% year on year). Return on equity was 10.8% in Mar 2026. Promoter holding was 45.63% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

DEEPAK FERT. trades 11.0% below its 52-week high and 69.8% above its 52-week low.

Change over period: —

1M+17.9%
3M+0.3%
6M+12.3%
1Y+4.8%

2 · The business

Is it growing?

Sales, year on year+22.5%

Jun 2026 revenue of ₹3,256 cr.

Profit, year on year+101.6%

Jun 2026 net profit of ₹490 cr.

Net margin15.0%

5.9 pts higher than a year earlier.

3-year growth-15.2% profit

Revenue compounded at 0.7% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue32563011283030062659266725792747
Net profit490139141213243277251210
Net margin %15.04.65.07.19.110.49.77.6
EPS (₹)38.8211.0411.2116.8919.2621.9619.8616.64

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue11506102748676113017663580846856742
Net profit73793444312106784008771
Net margin %6.49.15.110.78.96.91.91.0
EPS (₹)58.473.9535.0595.8656.2438.998.56.97

3 · The quality

How well does it turn capital into profit?

Return on equity was 10.8% in Mar 2026; debt to equity is 0.80.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %10.815.08.223.9
Return on capital %11.316.712.323.4
EBITDA margin %15.419.416.019.8
Net margin %6.39.05.010.6

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR0.7%14.7%
Profit CAGR-15.2%13.0%
Debt to equity0.80
Interest cover3.9x
Current ratio1.42
P/E ratio16.2

4 · The owners

Who holds it, and are they adding?

Promoter holding45.63%

Unchanged over 8 quarters.

Foreign institutions10.15%

Down 1.41 pts over 8 quarters.

Domestic institutions14.47%

Up 5.65 pts over 8 quarters.

Mutual fund schemes73

+14 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter45.6345.6345.6345.6345.6345.6345.6345.630.0
FII11.5610.7411.2510.9510.3110.3110.0210.15-1.41
DII8.8211.3212.2612.613.1713.2414.6914.47+5.65
Public33.9932.3130.8630.8230.8930.8229.6729.75-4.24

Mutual fund holdings · Oct 2026

73 schemes hold this stock

59 the month before.

  • SBI Long Term Advantage Fund - Series V5.36% of NAV
  • SBI Long Term Advantage Fund - Series VI2.42% of NAV
  • Old Bridge Flexi Cap Fund2.41% of NAV
  • Kotak Nifty Chemicals ETF2.23% of NAV
  • Groww Nifty Chemicals ETF2.23% of NAV
  • Invesco India Nifty Chemical Index Fund2.18% of NAV
  • SBI Resurgent India Opportunities Scheme1.62% of NAV
  • SBI Smallcap Fund1.48% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for DEEPAK FERT. are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about DEEPAK FERT.

What is the DEEPAK FERT. share price?

DEEPAK FERT. (DEEPAKFERT) last closed at ₹1,449.90, down 2.07% on the day. Its 52-week range is ₹872.10 to ₹1,664.30.

What is the market cap of DEEPAK FERT.?

DEEPAK FERT. has a market capitalisation of about ₹18,701 crore. Its price-to-earnings ratio is 16.2.

How are DEEPAK FERT.'s latest results?

DEEPAK FERT. reported revenue of ₹3,256 crore for Jun 2026, up 22.5% from a year earlier. Net profit was ₹490 crore (up 101.6% year on year). Return on equity was 10.8% in Mar 2026. Promoter holding was 45.63% in Sep 2026, up 0.00 points over 8 quarters.

Who owns DEEPAK FERT.?

As of Sep 2026, shareholding was: Promoter 45.63%, FII 10.15%, DII 14.47%, Public 29.75%.

How many mutual funds hold DEEPAK FERT.?

73 mutual fund schemes held DEEPAK FERT. in October 2026. That compares with 59 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 02 Sep 2025 · Dividend - Rs. 10
  • 03 Sep 2024 · Dividend - Rs. 8.5
  • 25 Aug 2023 · Dividend - Rs. 10
  • 25 Aug 2022 · Dividend - Rs. 9
  • 17 Aug 2021 · Dividend - Rs. 7.5
  • 16 Sep 2020 · Dividend - Rs. 3

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.